Loading... (0%)
About liver disease

2017 Half-Year Results: Cash Position at End of Period at €126M and Significant Advances in the Company’s Pipeline (press release)

et, adipiscing suscipit velit, elit. ante. massa mattis id ut facilisis Nullam